Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection : the CardioCOVID-Gemelli Study
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology..
BACKGROUND: Myocardial injury is prevalent among patients hospitalized for COVID-19. However, the role of COVID-19 vaccines in modifying the risk of myocardial injury is unknown.
OBJECTIVES: To assess the role of vaccines in modifying the risk of myocardial injury in COVID-19.
METHODS: We enrolled COVID-19 patients admitted from March 2021 to February 2022 with known vaccination status and ≥1 assessment of hs-cTnI within 30 days from the admission. The primary endpoint was the occurrence of myocardial injury (hs-cTnI levels >99th percentile upper reference limit).
RESULTS: 1019 patients were included (mean age 67.7±14.8 years, 60.8% male, 34.5% vaccinated against COVID-19). Myocardial injury occurred in 145 (14.2%) patients. At multivariate logistic regression analysis, advanced age, chronic kidney disease and hypertension, but not vaccination status, were independent predictors of myocardial injury. In the analysis according to age tertiles distribution, myocardial injury occurred more frequently in the III tertile (≥76 years) compared to other tertiles (I tertile:≤60 years;II tertile:61-75 years) (p<0.001). Moreover, in the III tertile, vaccination was protective against myocardial injury (OR 0.57, CI 95% 0.34-0.94; p=0.03), while a previous history of coronary artery disease was an independent positive predictor. In contrast, in the I tertile, chronic kidney disease (OR 6.94, 95% CI 1.31-36.79, p=0.02) and vaccination (OR 4.44, 95% CI 1.28-15.34, p=0.02) were independent positive predictors of myocardial injury.
CONCLUSIONS: In patients ≥76 years, COVID-19 vaccines were protective for the occurrence of myocardial injury, while in patients ≤60 years, myocardial injury was associated with previous COVID-19 vaccination. Further studies are warranted to clarify the underlying mechanisms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
European heart journal. Quality of care & clinical outcomes - (2024) vom: 27. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Montone, Rocco Antonio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 15.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1093/ehjqcco/qcae016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369041976 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369041976 | ||
| 003 | DE-627 | ||
| 005 | 20240415233303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ehjqcco/qcae016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM369041976 | ||
| 035 | |a (NLM)38414273 | ||
| 035 | |a (PII)qcae016 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Montone, Rocco Antonio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection |b the CardioCOVID-Gemelli Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. | ||
| 520 | |a BACKGROUND: Myocardial injury is prevalent among patients hospitalized for COVID-19. However, the role of COVID-19 vaccines in modifying the risk of myocardial injury is unknown | ||
| 520 | |a OBJECTIVES: To assess the role of vaccines in modifying the risk of myocardial injury in COVID-19 | ||
| 520 | |a METHODS: We enrolled COVID-19 patients admitted from March 2021 to February 2022 with known vaccination status and ≥1 assessment of hs-cTnI within 30 days from the admission. The primary endpoint was the occurrence of myocardial injury (hs-cTnI levels >99th percentile upper reference limit) | ||
| 520 | |a RESULTS: 1019 patients were included (mean age 67.7±14.8 years, 60.8% male, 34.5% vaccinated against COVID-19). Myocardial injury occurred in 145 (14.2%) patients. At multivariate logistic regression analysis, advanced age, chronic kidney disease and hypertension, but not vaccination status, were independent predictors of myocardial injury. In the analysis according to age tertiles distribution, myocardial injury occurred more frequently in the III tertile (≥76 years) compared to other tertiles (I tertile:≤60 years;II tertile:61-75 years) (p<0.001). Moreover, in the III tertile, vaccination was protective against myocardial injury (OR 0.57, CI 95% 0.34-0.94; p=0.03), while a previous history of coronary artery disease was an independent positive predictor. In contrast, in the I tertile, chronic kidney disease (OR 6.94, 95% CI 1.31-36.79, p=0.02) and vaccination (OR 4.44, 95% CI 1.28-15.34, p=0.02) were independent positive predictors of myocardial injury | ||
| 520 | |a CONCLUSIONS: In patients ≥76 years, COVID-19 vaccines were protective for the occurrence of myocardial injury, while in patients ≤60 years, myocardial injury was associated with previous COVID-19 vaccination. Further studies are warranted to clarify the underlying mechanisms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a clinical predictors | |
| 650 | 4 | |a myocardial injury | |
| 650 | 4 | |a vaccines | |
| 700 | 1 | |a Rinaldi, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Masciocchi, Carlotta |e verfasserin |4 aut | |
| 700 | 1 | |a Lilli, Livia |e verfasserin |4 aut | |
| 700 | 1 | |a Damiani, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a La Vecchia, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Iannaccone, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Basile, Mattia |e verfasserin |4 aut | |
| 700 | 1 | |a Salzillo, Carmine |e verfasserin |4 aut | |
| 700 | 1 | |a Caffè, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Bonanni, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a De Pascale, Gennaro |e verfasserin |4 aut | |
| 700 | 1 | |a Grieco, Domenico Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Tanzarella, Eloisa Sofia |e verfasserin |4 aut | |
| 700 | 1 | |a Buonsenso, Danilo |e verfasserin |4 aut | |
| 700 | 1 | |a Murri, Rita |e verfasserin |4 aut | |
| 700 | 1 | |a Fantoni, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Liuzzo, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Sanna, Tommaso |e verfasserin |4 aut | |
| 700 | 1 | |a Richeldi, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Sanguinetti, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Massetti, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Trani, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Tshomba, Yamume |e verfasserin |4 aut | |
| 700 | 1 | |a Gasbarrini, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Valentini, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Antonelli, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Crea, Filippo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European heart journal. Quality of care & clinical outcomes |d 2015 |g (2024) vom: 27. Feb. |w (DE-627)NLM259053279 |x 2058-1742 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:27 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ehjqcco/qcae016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 27 |c 02 | ||